We produce immunotherapies adapted for each animal species by using DNA platform technology. Our medicines optimize the gene sequence that prevents and treats diseases and it is inserted into the cell via electroporation
Through our DNA platform technology, we strive to develop animal-specific drugs that treat a wide range of conditions such as cancer, anemia, swine immunomodulators, foot-and-mouth disease and infectious virus diseases
Plumbline develops different medicines customized to various animal species. This is thanks to our DNA plasmid-based platform technology, which self-activates after it is introduced into the cell.